FDA Creates Guide to Help Find Right FDA Office
Published Date: 11/26/2025
Notice
Summary
The FDA just dropped a draft guide to help companies know exactly where to send their master files when they support multiple product reviews across different FDA centers. This makes the process smoother for folks working with drugs, biologics, devices, and veterinary products. If you’re in the industry, check it out and send your feedback by February 24, 2026—no fees, just better clarity and faster reviews!
Analyzed Economic Effects
5 provisions identified: 4 benefits, 1 costs, 0 mixed.
Where to Submit Cross‑Center Master Files
If you hold a master file that may be accessed by more than one FDA center, FDA published a draft guidance that gives recommendations on which center to submit that master file. The recommendations explicitly cover submissions to CBER, CDER, and CDRH and to certain types of CVM master files.
CVM Types VI–VIII Are Excluded
The draft guidance applies to master files submitted to the Center for Veterinary Medicine (CVM) except it does not apply to CVM veterinary master file types VI, VII, and VIII and their Public Master Files. Holders of those CVM master file types are not covered by these recommendations.
Draft Guidance Is Non‑Binding
The document is a draft guidance and, as stated, represents FDA's current thinking and is not binding on FDA or the public. You may use an alternative approach if it satisfies the applicable statutes and regulations.
No New Paperwork Under PRA
The draft guidance contains no new collection of information under the Paperwork Reduction Act. It refers to previously approved FDA collections with OMB control numbers such as 0910-0001, 0910-0014, 0910-0338, 0910-0032, and others.
Applies to New Master File Submissions
FDA states that the recommendations, once finalized, are intended for new master file submissions going forward. The draft guidance asks for comments by February 24, 2026 as FDA develops the final guidance.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2026-16939, GNT USA, LLC.; Filing of Color Additive Petition
The Food and Drug Administration (FDA or we) is announcing that we have filed a petition, submitted by GNT USA, LLC., c/o Exponent, Inc., proposing that we amend our color additive regulations to provide for the safe use of safflower (Carthamus tinctorius L.) extract as a color additive in various foods at levels consistent with good manufacturing practices.
2026-16942, Food Additives Permitted in Feed and Drinking Water of Animals; Chromium DL-methionine Chelate
The Food and Drug Administration (FDA, we, or the Agency) is amending the regulations for food additives permitted in feed and drinking water of animals to provide for the safe use of chromium DL- methionine chelate as a nutritional source of chromium in cattle feed. This action is in response to a food additive petition filed by Zinpro Corp.
2026-16944, Gardenia Blue Interest Group; Filing of Color Additive Petition
The Food and Drug Administration (FDA or we) is announcing that we have filed a petition, submitted by Gardenia Blue Interest Group (GBIG or petitioner), c/o Exponent, Inc., proposing that we amend our color additive regulations to expand the safe use of gardenia (genipin) blue in various foods at levels consistent with good manufacturing practice. The petition also proposes to lower the specification for arsenic in gardenia (genipin) blue.
Previous / Next Documents
Previous: 2025-21223, Notice of Public Meetings of the Missouri Advisory Committee to the U.S. Commission on Civil Rights
The Missouri Advisory Committee to the U.S. Commission on Civil Rights is holding a public meeting on December 9, 2025, to review a report about Curriculum Censorship. Anyone interested can join by phone or Zoom, share their thoughts, or send written comments within 30 days. This is a great chance for Missouri residents to have their voices heard on important education issues.
Next: 2025-21225, Notice of OFAC Sanctions Action
The U.S. Treasury’s OFAC just blocked the property of Hasan Qahtan Al-Sa’idi and others linked to the Islamic Revolutionary Guard Corps, making it illegal for Americans to do business with them. This action, effective October 9, 2025, freezes their U.S.-based assets and cuts off financial ties. It’s a big move to stop support for terrorism and protect U.S. interests.